Related Experiment Videos
[Renal toxicity by intraperitoneal administration of CDDP]
J T Chen1, T Yamashiro, Y Shimizu
1Department of Gynecology, Cancer Institute Hospital, Tokyo.
Nihon Sanka Fujinka Gakkai Zasshi
|May 1, 1988
Summary
High-dose cisplatin (CDDP) and same-day administration with surgery increase renal toxicity risk in ovarian cancer patients. Maintaining renal blood flow and monitoring FDP levels may prevent kidney damage during CDDP therapy.
Area of Science:
- Oncology
- Nephrology
- Pharmacology